Bank of Montreal Can grew its position in shares of Natus Medical Inc (NASDAQ:BABY) by 11.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 45,206 shares of the medical equipment provider’s stock after purchasing an additional 4,615 shares during the quarter. Bank of Montreal Can owned 0.15% of Natus Medical worth $1,728,000 as of its most recent filing with the SEC.
Other hedge funds have also recently modified their holdings of the company. Eqis Capital Management Inc. increased its position in shares of Natus Medical by 25.0% during the 3rd quarter. Eqis Capital Management Inc. now owns 16,740 shares of the medical equipment provider’s stock valued at $628,000 after purchasing an additional 3,353 shares during the period. Capital Management Associates NY acquired a new position in shares of Natus Medical during the 3rd quarter valued at $412,000. JPMorgan Chase & Co. increased its position in shares of Natus Medical by 13.4% during the 3rd quarter. JPMorgan Chase & Co. now owns 37,767 shares of the medical equipment provider’s stock valued at $1,411,000 after purchasing an additional 4,457 shares during the period. Wells Fargo & Company MN increased its position in shares of Natus Medical by 24.7% during the 3rd quarter. Wells Fargo & Company MN now owns 99,741 shares of the medical equipment provider’s stock valued at $3,740,000 after purchasing an additional 19,726 shares during the period. Finally, Eagle Asset Management Inc. increased its position in shares of Natus Medical by 18.8% during the 3rd quarter. Eagle Asset Management Inc. now owns 499,376 shares of the medical equipment provider’s stock valued at $19,076,000 after purchasing an additional 79,170 shares during the period. Institutional investors own 93.91% of the company’s stock.
BABY has been the topic of several research analyst reports. Benchmark reiterated a “buy” rating and set a $49.00 price target (down from $55.00) on shares of Natus Medical in a research report on Tuesday, January 16th. Zacks Investment Research upgraded Natus Medical from a “hold” rating to a “buy” rating and set a $45.00 price target on the stock in a research report on Tuesday, October 24th. BidaskClub cut Natus Medical from a “hold” rating to a “sell” rating in a research report on Saturday, December 9th. Finally, William Blair cut Natus Medical from an “outperform” rating to a “market perform” rating in a research report on Monday, January 8th. Two equities research analysts have rated the stock with a sell rating, one has issued a hold rating and one has issued a buy rating to the company. The company has a consensus rating of “Hold” and an average target price of $47.00.
Natus Medical Inc (BABY) traded down $0.30 on Wednesday, hitting $30.55. The stock had a trading volume of 304,500 shares, compared to its average volume of 711,540. The company has a market cap of $961.11, a price-to-earnings ratio of -49.27 and a beta of 0.56. The company has a current ratio of 3.32, a quick ratio of 2.54 and a debt-to-equity ratio of 0.37. Natus Medical Inc has a 1-year low of $28.00 and a 1-year high of $43.60.
Natus Medical (NASDAQ:BABY) last released its quarterly earnings data on Wednesday, February 7th. The medical equipment provider reported $0.42 earnings per share for the quarter, missing the consensus estimate of $0.54 by ($0.12). The company had revenue of $131.40 million for the quarter, compared to the consensus estimate of $131.38 million. Natus Medical had a positive return on equity of 11.36% and a negative net margin of 4.05%. The business’s revenue was up 22.0% compared to the same quarter last year. During the same period in the prior year, the business earned $0.51 earnings per share. equities research analysts expect that Natus Medical Inc will post 1.63 EPS for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: “Bank of Montreal Can Grows Stake in Natus Medical Inc (BABY)” was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are reading this story on another publication, it was illegally stolen and republished in violation of US & international trademark and copyright law. The legal version of this story can be read at https://www.dispatchtribunal.com/2018/02/21/bank-of-montreal-can-has-1-73-million-holdings-in-natus-medical-inc-baby.html.
Natus Medical Profile
Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and balance and mobility disorders.
Receive News & Ratings for Natus Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natus Medical and related companies with MarketBeat.com's FREE daily email newsletter.